Replies to post #818229 on NorthWest Biotherapeutics Inc (NWBO)

[Zadie420]

That is true. This was part of criterion that a patient has failed other treatment[s] before they use DCVax-D.
But we are still sitting on .20. Shame on LP.
She couldn't move this trial for any cancer to P2 [DCVax-D]. We knew about this for the last 6 years.